HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)
China · Delayed Price · Currency is CNY 8.31
-0.06 (-0.72%)
Jun 11, 2026, 9:59 AM CST
SHA:600829 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 136.46 | 133.84 | 213.27 | 292.16 | 264.48 | 277.3 |
Depreciation & Amortization | 57.42 | 57.42 | 61.54 | 60.18 | 63.99 | 60.44 |
Other Amortization | 5.62 | 5.62 | 3.53 | 5.92 | 4.5 | 4.33 |
Loss (Gain) From Sale of Assets | 0.44 | 0.44 | -0.23 | 0.35 | 0.36 | -0.07 |
Asset Writedown & Restructuring Costs | 2.26 | 2.26 | 2.15 | 0.81 | 0.3 | 1.95 |
Loss (Gain) From Sale of Investments | - | - | -13.9 | -3.89 | - | - |
Provision & Write-off of Bad Debts | 59.97 | 59.97 | 19.24 | 24.85 | -11.08 | 9.17 |
Other Operating Activities | -14.76 | 24.22 | 28.22 | 27.02 | 27.01 | 17.82 |
Change in Accounts Receivable | 163.19 | 163.19 | -10.6 | -228.88 | 0.7 | -292.96 |
Change in Inventory | -129.47 | -129.47 | 16.45 | -41.41 | 31.22 | 17.35 |
Change in Accounts Payable | -1.15 | -1.15 | -204.15 | 201.01 | -76.03 | -326.39 |
Operating Cash Flow | 263.61 | 299.98 | 115.44 | 332.99 | 307.33 | -233 |
Operating Cash Flow Growth | 76.91% | 159.86% | -65.33% | 8.35% | - | - |
Capital Expenditures | -17.74 | -17.16 | -8.04 | -23.48 | -6.42 | -12.24 |
Sale of Property, Plant & Equipment | 0.1 | 0.13 | 0.15 | 0.26 | 0.55 | 0.69 |
Other Investing Activities | - | - | - | -156.64 | - | - |
Investing Cash Flow | -17.65 | -17.02 | -7.89 | -179.86 | -5.87 | -11.55 |
Short-Term Debt Issued | - | 790 | 949.22 | 681.73 | 1,392 | 1,320 |
Total Debt Issued | 872.4 | 790 | 949.22 | 681.73 | 1,392 | 1,320 |
Short-Term Debt Repaid | - | -840.6 | -1,072 | -917.8 | -1,299 | -699 |
Long-Term Debt Repaid | - | -42.5 | -42.19 | -46.42 | -42.75 | -44.93 |
Total Debt Repaid | -983.1 | -883.1 | -1,114 | -964.22 | -1,342 | -743.93 |
Net Debt Issued (Repaid) | -110.7 | -93.1 | -165.05 | -282.49 | 50.12 | 575.74 |
Common Dividends Paid | -13.6 | -20.08 | -160.41 | -24.62 | -30.48 | -35.65 |
Other Financing Activities | -5.5 | - | - | 424.97 | 129.88 | -197.78 |
Financing Cash Flow | -129.79 | -113.18 | -325.46 | 117.86 | 149.51 | 342.31 |
Net Cash Flow | 116.17 | 169.78 | -217.92 | 270.99 | 450.97 | 97.76 |
Free Cash Flow | 245.87 | 282.82 | 107.39 | 309.5 | 300.91 | -245.24 |
Free Cash Flow Growth | 73.83% | 163.34% | -65.30% | 2.85% | - | - |
Free Cash Flow Margin | 2.33% | 2.73% | 1.07% | 2.98% | 3.12% | -2.63% |
Free Cash Flow Per Share | 0.42 | 0.49 | 0.18 | 0.53 | 0.52 | -0.42 |
Cash Income Tax Paid | 262.37 | 256.61 | 305.32 | 281.41 | 254.71 | 281.28 |
Levered Free Cash Flow | 272.38 | 347.5 | -16.7 | 366.86 | 406.36 | -152 |
Unlevered Free Cash Flow | 287.48 | 362.81 | 0.98 | 383.88 | 434.13 | -120.55 |
Change in Working Capital | 16.2 | 16.2 | -198.39 | -74.41 | -42.23 | -603.92 |